NIKOLAI KINACHTCHOUK: Open Payments
NPI 1306830963 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 62 payments from 22 companies in 2025. Trend: 2023 $1,322 · 2024 $1,632 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $164 |
| Abbott Laboratories | 5 | $119 |
| Lilly USA, LLC | 7 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $113 |
| Novo Nordisk Inc | 5 | $102 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Amgen Inc. | 3 | $57 |
| PFIZER INC. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
Products named: FREESTYLE LIBRE 3, FARXIGA, JARDIANCE, GARDASIL 9, MOUNJARO, ELIQUIS, AIRSUPRA, Ozempic.
Industry payments across MI — which companies pay providers there.
